Skip to content
Mainboard BSE,NSE Bidding closed

Gujarat Kidney And Super Speciality IPO Subscription Status

Gujarat Kidney And Super Speciality IPO received bids for 6,89,69,088 shares against 1,32,26,880 offered, an overall subscription of 5.21x at the close of bidding (24 Dec 2025). Retail leads at 19.04x.

Last updated · day 3 figures

Retail
19.04x
NII
5.73x
QIB
1.06x
Total
5.21x

Where the demand is

Gujarat Kidney And Super Speciality IPO subscription by category Each line starts at 1x (fully subscribed) and ends at the category's subscription multiple, on a logarithmic scale. Values are listed in the table below. 0.1x 1x 10x 100x QIB QIB: 1.06x 1.06x NII NII: 5.73x 5.73x bNII bNII: 5.25x 5.25x sNII sNII: 6.68x 6.68x Retail Retail: 19.04x 19.04x Total Total: 5.21x 5.21x
Log scale. Lines run from 1x (fully subscribed): right means more demand than shares, left means shares still unbid.

Gujarat Kidney And Super Speciality IPO subscription by category

Category Shares offered Shares bid Amount bid Subscription
QIB 77,26,880 81,88,928 ₹93.35 Cr 1.06x
NII 33,00,000 1,88,99,840 ₹215.46 Cr 5.73x
bNII above ₹10 lakh 22,00,000 1,15,52,896 ₹131.70 Cr 5.25x
sNII ₹2–10 lakh 11,00,000 73,46,944 ₹83.76 Cr 6.68x
Retail 22,00,000 4,18,80,320 ₹477.44 Cr 19.04x
Total 1,32,26,880 6,89,69,088 ₹786.25 Cr 5.21x

* Shares Offered and Total Amount are calculated based on the upper price of the issue price range. * The portion of anchor investors (or market makers) is not included in the total number of shares offered.

Gujarat Kidney And Super Speciality IPO subscription day-wise

Category Day 3
QIB 1.06x
NII 5.73x
bNII 5.25x
sNII 6.68x
Retail 19.04x
Total 5.21x
Total added 5.21x

Cumulative figures at the end of each day. Read across a row to see how demand built up. Shading deepens as subscription rises above 1x; "Total added" is how much overall subscription grew that day.

Gujarat Kidney And Super Speciality IPO reservation

Category Shares Share of issue
Qualified Institutional Buyers 77,26,880 58.42%
Non-Institutional Investors 33,00,000 24.95%
bNII · above ₹10 lakh 22,00,000 67% of NII
sNII · ₹2–10 lakh 11,00,000 33% of NII
Retail Individual Investors 22,00,000 16.63%
Public issue 1,32,26,880 100%

Allotment Chances Note

These are estimates from the latest application and subscription figures. Actual chances are usually somewhat better, because:

  • Not every bid is at the cut-off price. Bids below the final issue price are rejected before the lottery, so fewer applications compete.
  • Multiple-lot applications count once. In an oversubscribed retail or sNII portion, each application gets at most one minimum lot in the draw, however many lots it bid for.
  • Invalid applications drop out. Unapproved UPI mandates, PAN mismatches and duplicate applications are removed before allotment.

Applying for more lots in the retail category does not improve your odds; applying from separate family accounts does.

Gujarat Kidney And Super Speciality IPO subscription: FAQs

What is the overall subscription of Gujarat Kidney And Super Speciality IPO?
Gujarat Kidney And Super Speciality IPO is subscribed 5.21x overall as of day 3 (24 December 2025), with bids for 6,89,69,088 shares against 1,32,26,880 offered.
What is the retail subscription of Gujarat Kidney And Super Speciality IPO?
The retail portion is subscribed 19.04x as of day 3 (24 December 2025).
What is the QIB and NII subscription of Gujarat Kidney And Super Speciality IPO?
QIBs have subscribed 1.06x of their portion, and NIIs 5.73x (bNII 5.25x, sNII 6.68x) as of day 3 (24 December 2025).
How can I check Gujarat Kidney And Super Speciality IPO subscription status live?
This page shows category-wise and day-wise figures and is updated during bidding hours. The same data is published on the BSE and NSE websites under the issue name.
How do I apply for Gujarat Kidney And Super Speciality IPO?
Apply online through your broker or bank using UPI or ASBA. Choose the IPO, enter the number of lots and bid price (retail investors can bid at the cut-off price), and approve the UPI mandate before the issue closes on 24 December 2025.

Subscription figures are compiled from BSE and NSE bid data and can be revised by the exchanges after the issue closes. For information only; not investment advice.